| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.3M | +1106.2% |
| Cost of Revenue | $91.5M | +204.9% |
| R&D Expense | $33.3M | -69.1% |
| Operating Income | -$348.9M | +9.9% |
| Pre-tax Income | -$343.1M | -21.5% |
| Income Tax | $0 | — |
| Net Income | -$343.1M | -21.5% |
| EPS (Basic) | -$21.67 | -1505.2% |
| EPS (Diluted) | -$21.67 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $87.1M | -28.2% |
| Short-term Investments | $100.3M | +0.0% |
| Inventory | $13.7M | +0.0% |
| Current Assets | $92.1M | -64.0% |
| Total Assets | $92.2M | -79.6% |
| Current Liabilities | $15.4M | -77.6% |
| Total Liabilities | $45.9M | -34.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$137.2M | +35.8% |
| Capital Expenditures | $10.2M | -81.4% |
| Investing Cash Flow | $102.9M | +189.6% |
| Financing Cash Flow | $206.0M | +0.0% |
| Free Cash Flow | -$147.3M | +45.1% |
| -1505.2% |
| Stockholders' Equity |
| $13.5M |
| -96.1% |